COVID-19 Pandemic: Global Impact and Potential Implications for Cardiovascular Disease in Canada.
Identifieur interne : 000371 ( Main/Exploration ); précédent : 000370; suivant : 000372COVID-19 Pandemic: Global Impact and Potential Implications for Cardiovascular Disease in Canada.
Auteurs : Leigh C P. Botly [Canada] ; Michelle Martin-Rhee [Canada] ; Adrienne Kasiban [Canada] ; Richard H. Swartz [Canada] ; Sharon L. Mulvagh [États-Unis] ; M Patrice Lindsay [Canada] ; Cristina Goia [Canada] ; Eric E. Smith [Canada] ; Michael D. Hill [Canada] ; Thalia S. Field [Canada] ; Andrew D. Krahn [Canada] ; Gavin Y. Oudit [Canada] ; Shelley Zieroth [Canada] ; Cindy Y Y. Yip [Canada]Source :
- CJC open [ 2589-790X ] ; 2020.
Abstract
Background
The literature indicates that cardiovascular disease (CVD; including stroke), older age, and availability of health care resources affect COVID-19 case fatality rates (CFRs). The cumulative effect of COVID-19 CFRs in global CVD populations and the extrapolated effect on access to health care services in the CVD population in Canada are not fully known. In this study we explored the relationships of factors that might affect COVID-19 CFRs and estimated the potential indirect effects of COVID-19 on Canadian health care resources.
Methods
Country-level epidemiological data were analyzed to study the correlation, main effect, and interaction between COVID-19 CFRs and: (1) the proportion of the population with CVD; (2) the proportion of the population 65 years of age or older; and (3) the availability of essential health services as defined by the World Health Organization Universal Health Coverage index. For indirect implications on health care resources, estimates of the volume of postponed coronary artery bypass grafting, percutaneous coronary intervention, and valve surgeries in Ontario were calculated.
Results
Positive correlations were found between COVID-19 CFRs and: (1) the proportion of the population with CVD (ρ = 0.40;
Conclusions
Countries with more prevalent CVD reported higher COVID-19 CFRs. Strain on health care resources is likely in Canada.
Contexte
La littérature indique que les maladies cardiovasculaires (MCV, incluant les accidents vasculaires cérébraux), l’âge avancé et la facilité d’accès aux ressources de soins de santé ont une incidence sur les taux de létalité (TL) des cas de COVID-19. L’effet cumulatif du TL de la COVID-19 dans l’ensemble de la population atteinte de MCV et l’impact anticipé sur l'accès aux services de santé dans la population atteinte de MCV au Canada ne sont pas entièrement connus. Cette étude a exploré les liens entre les facteurs pouvant influencer le TL des cas de COVID-19 et a estimé le potentiel impact indirect de la COVID-19 sur les ressources de soins de santé au Canada.
Méthodes
Les données épidémiologiques à l’échelle du pays ont été analysées pour étudier la corrélation, l’effet principal et l’interaction entre le TL de laCOVID-19 et : 1) la proportion de la population souffrant de MCV, 2) la proportion de la population ≥ 65 ans, et 3) l’accessibilité des services de santé essentiels tels que définis par l’indice de couverture sanitaire universelle (CSU) de l’Organisation Mondiale de la Santé. Pour les implications indirectes concernant les ressources de santé, des estimations du volume d’opération de pontages coronariens, d'interventions coronariennes percutanées et de chirurgies valvulaires reportées en Ontario ont été calculées.
Résultats
Des corrélations positives ont été trouvées entre le TL de la COVID-19 et 1) la proportion de la population souffrant de MCV (ρ= 0,40,
Conclusions
Les pays où les MCV sont plus répandues ont signalé un TL de la COVID-19 plus élevé. Il est probable que les ressources de soins de santé soient soumises à de fortes contraintes au Canada.
DOI: 10.1016/j.cjco.2020.06.003
PubMed: 32691023
PubMed Central: PMC7275173
Affiliations:
- Canada, États-Unis
- Alberta, Manitoba, Ontario
- Calgary, Toronto, Winnipeg
- Université de Calgary, Université de Toronto, Université du Manitoba
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">COVID-19 Pandemic: Global Impact and Potential Implications for Cardiovascular Disease in Canada.</title><author><name sortKey="Botly, Leigh C P" sort="Botly, Leigh C P" uniqKey="Botly L" first="Leigh C P" last="Botly">Leigh C P. Botly</name><affiliation wicri:level="1"><nlm:affiliation>Heart and Stroke Foundation of Canada, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Heart and Stroke Foundation of Canada, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Martin Rhee, Michelle" sort="Martin Rhee, Michelle" uniqKey="Martin Rhee M" first="Michelle" last="Martin-Rhee">Michelle Martin-Rhee</name><affiliation wicri:level="1"><nlm:affiliation>Heart and Stroke Foundation of Canada, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Heart and Stroke Foundation of Canada, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Kasiban, Adrienne" sort="Kasiban, Adrienne" uniqKey="Kasiban A" first="Adrienne" last="Kasiban">Adrienne Kasiban</name><affiliation wicri:level="1"><nlm:affiliation>Heart and Stroke Foundation of Canada, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Heart and Stroke Foundation of Canada, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Swartz, Richard H" sort="Swartz, Richard H" uniqKey="Swartz R" first="Richard H" last="Swartz">Richard H. Swartz</name><affiliation wicri:level="4"><nlm:affiliation>Sunnybrook Health Sciences Centre and Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Sunnybrook Health Sciences Centre and Sunnybrook Research Institute, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Mulvagh, Sharon L" sort="Mulvagh, Sharon L" uniqKey="Mulvagh S" first="Sharon L" last="Mulvagh">Sharon L. Mulvagh</name><affiliation wicri:level="1"><nlm:affiliation>Division of Cardiology, Dalhousie University, Halifax, Nova Scotia, Canada, and Department of Cardiovascular Medicine, Mayo Clinic, Rochester Minnesota, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Cardiology, Dalhousie University, Halifax, Nova Scotia, Canada, and Department of Cardiovascular Medicine, Mayo Clinic, Rochester Minnesota</wicri:regionArea><wicri:noRegion>Rochester Minnesota</wicri:noRegion></affiliation></author><author><name sortKey="Lindsay, M Patrice" sort="Lindsay, M Patrice" uniqKey="Lindsay M" first="M Patrice" last="Lindsay">M Patrice Lindsay</name><affiliation wicri:level="1"><nlm:affiliation>Heart and Stroke Foundation of Canada, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Heart and Stroke Foundation of Canada, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Goia, Cristina" sort="Goia, Cristina" uniqKey="Goia C" first="Cristina" last="Goia">Cristina Goia</name><affiliation wicri:level="1"><nlm:affiliation>Heart and Stroke Foundation of Canada, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Heart and Stroke Foundation of Canada, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Smith, Eric E" sort="Smith, Eric E" uniqKey="Smith E" first="Eric E" last="Smith">Eric E. Smith</name><affiliation wicri:level="4"><nlm:affiliation>Hotchkiss Brain Institute, Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Hotchkiss Brain Institute, Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta</wicri:regionArea><orgName type="university">Université de Calgary</orgName><placeName><settlement type="city">Calgary</settlement><region type="state">Alberta</region></placeName></affiliation></author><author><name sortKey="Hill, Michael D" sort="Hill, Michael D" uniqKey="Hill M" first="Michael D" last="Hill">Michael D. Hill</name><affiliation wicri:level="4"><nlm:affiliation>Hotchkiss Brain Institute, Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Hotchkiss Brain Institute, Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta</wicri:regionArea><orgName type="university">Université de Calgary</orgName><placeName><settlement type="city">Calgary</settlement><region type="state">Alberta</region></placeName></affiliation></author><author><name sortKey="Field, Thalia S" sort="Field, Thalia S" uniqKey="Field T" first="Thalia S" last="Field">Thalia S. Field</name><affiliation wicri:level="1"><nlm:affiliation>Vancouver Stroke Program, Division of Neurology, University of British Columbia, Vancouver, British Columbia, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Vancouver Stroke Program, Division of Neurology, University of British Columbia, Vancouver, British Columbia</wicri:regionArea><wicri:noRegion>British Columbia</wicri:noRegion></affiliation></author><author><name sortKey="Krahn, Andrew D" sort="Krahn, Andrew D" uniqKey="Krahn A" first="Andrew D" last="Krahn">Andrew D. Krahn</name><affiliation wicri:level="1"><nlm:affiliation>Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, and St Paul's and Vancouver General Hospital, Vancouver, British Columbia, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, and St Paul's and Vancouver General Hospital, Vancouver, British Columbia</wicri:regionArea><wicri:noRegion>British Columbia</wicri:noRegion></affiliation></author><author><name sortKey="Oudit, Gavin Y" sort="Oudit, Gavin Y" uniqKey="Oudit G" first="Gavin Y" last="Oudit">Gavin Y. Oudit</name><affiliation wicri:level="1"><nlm:affiliation>Division of Cardiology, Department of Medicine, and Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Cardiology, Department of Medicine, and Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta</wicri:regionArea><wicri:noRegion>Alberta</wicri:noRegion></affiliation></author><author><name sortKey="Zieroth, Shelley" sort="Zieroth, Shelley" uniqKey="Zieroth S" first="Shelley" last="Zieroth">Shelley Zieroth</name><affiliation wicri:level="4"><nlm:affiliation>University of Manitoba, Winnipeg, Manitoba, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>University of Manitoba, Winnipeg, Manitoba</wicri:regionArea><orgName type="university">Université du Manitoba</orgName><placeName><settlement type="city">Winnipeg</settlement><region type="state">Manitoba</region></placeName></affiliation></author><author><name sortKey="Yip, Cindy Y Y" sort="Yip, Cindy Y Y" uniqKey="Yip C" first="Cindy Y Y" last="Yip">Cindy Y Y. Yip</name><affiliation wicri:level="1"><nlm:affiliation>Heart and Stroke Foundation of Canada, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Heart and Stroke Foundation of Canada, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32691023</idno><idno type="pmid">32691023</idno><idno type="doi">10.1016/j.cjco.2020.06.003</idno><idno type="pmc">PMC7275173</idno><idno type="wicri:Area/Main/Corpus">000024</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000024</idno><idno type="wicri:Area/Main/Curation">000024</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000024</idno><idno type="wicri:Area/Main/Exploration">000024</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">COVID-19 Pandemic: Global Impact and Potential Implications for Cardiovascular Disease in Canada.</title><author><name sortKey="Botly, Leigh C P" sort="Botly, Leigh C P" uniqKey="Botly L" first="Leigh C P" last="Botly">Leigh C P. Botly</name><affiliation wicri:level="1"><nlm:affiliation>Heart and Stroke Foundation of Canada, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Heart and Stroke Foundation of Canada, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Martin Rhee, Michelle" sort="Martin Rhee, Michelle" uniqKey="Martin Rhee M" first="Michelle" last="Martin-Rhee">Michelle Martin-Rhee</name><affiliation wicri:level="1"><nlm:affiliation>Heart and Stroke Foundation of Canada, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Heart and Stroke Foundation of Canada, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Kasiban, Adrienne" sort="Kasiban, Adrienne" uniqKey="Kasiban A" first="Adrienne" last="Kasiban">Adrienne Kasiban</name><affiliation wicri:level="1"><nlm:affiliation>Heart and Stroke Foundation of Canada, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Heart and Stroke Foundation of Canada, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Swartz, Richard H" sort="Swartz, Richard H" uniqKey="Swartz R" first="Richard H" last="Swartz">Richard H. Swartz</name><affiliation wicri:level="4"><nlm:affiliation>Sunnybrook Health Sciences Centre and Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Sunnybrook Health Sciences Centre and Sunnybrook Research Institute, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Mulvagh, Sharon L" sort="Mulvagh, Sharon L" uniqKey="Mulvagh S" first="Sharon L" last="Mulvagh">Sharon L. Mulvagh</name><affiliation wicri:level="1"><nlm:affiliation>Division of Cardiology, Dalhousie University, Halifax, Nova Scotia, Canada, and Department of Cardiovascular Medicine, Mayo Clinic, Rochester Minnesota, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Cardiology, Dalhousie University, Halifax, Nova Scotia, Canada, and Department of Cardiovascular Medicine, Mayo Clinic, Rochester Minnesota</wicri:regionArea><wicri:noRegion>Rochester Minnesota</wicri:noRegion></affiliation></author><author><name sortKey="Lindsay, M Patrice" sort="Lindsay, M Patrice" uniqKey="Lindsay M" first="M Patrice" last="Lindsay">M Patrice Lindsay</name><affiliation wicri:level="1"><nlm:affiliation>Heart and Stroke Foundation of Canada, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Heart and Stroke Foundation of Canada, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Goia, Cristina" sort="Goia, Cristina" uniqKey="Goia C" first="Cristina" last="Goia">Cristina Goia</name><affiliation wicri:level="1"><nlm:affiliation>Heart and Stroke Foundation of Canada, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Heart and Stroke Foundation of Canada, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Smith, Eric E" sort="Smith, Eric E" uniqKey="Smith E" first="Eric E" last="Smith">Eric E. Smith</name><affiliation wicri:level="4"><nlm:affiliation>Hotchkiss Brain Institute, Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Hotchkiss Brain Institute, Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta</wicri:regionArea><orgName type="university">Université de Calgary</orgName><placeName><settlement type="city">Calgary</settlement><region type="state">Alberta</region></placeName></affiliation></author><author><name sortKey="Hill, Michael D" sort="Hill, Michael D" uniqKey="Hill M" first="Michael D" last="Hill">Michael D. Hill</name><affiliation wicri:level="4"><nlm:affiliation>Hotchkiss Brain Institute, Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Hotchkiss Brain Institute, Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta</wicri:regionArea><orgName type="university">Université de Calgary</orgName><placeName><settlement type="city">Calgary</settlement><region type="state">Alberta</region></placeName></affiliation></author><author><name sortKey="Field, Thalia S" sort="Field, Thalia S" uniqKey="Field T" first="Thalia S" last="Field">Thalia S. Field</name><affiliation wicri:level="1"><nlm:affiliation>Vancouver Stroke Program, Division of Neurology, University of British Columbia, Vancouver, British Columbia, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Vancouver Stroke Program, Division of Neurology, University of British Columbia, Vancouver, British Columbia</wicri:regionArea><wicri:noRegion>British Columbia</wicri:noRegion></affiliation></author><author><name sortKey="Krahn, Andrew D" sort="Krahn, Andrew D" uniqKey="Krahn A" first="Andrew D" last="Krahn">Andrew D. Krahn</name><affiliation wicri:level="1"><nlm:affiliation>Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, and St Paul's and Vancouver General Hospital, Vancouver, British Columbia, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, and St Paul's and Vancouver General Hospital, Vancouver, British Columbia</wicri:regionArea><wicri:noRegion>British Columbia</wicri:noRegion></affiliation></author><author><name sortKey="Oudit, Gavin Y" sort="Oudit, Gavin Y" uniqKey="Oudit G" first="Gavin Y" last="Oudit">Gavin Y. Oudit</name><affiliation wicri:level="1"><nlm:affiliation>Division of Cardiology, Department of Medicine, and Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Cardiology, Department of Medicine, and Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta</wicri:regionArea><wicri:noRegion>Alberta</wicri:noRegion></affiliation></author><author><name sortKey="Zieroth, Shelley" sort="Zieroth, Shelley" uniqKey="Zieroth S" first="Shelley" last="Zieroth">Shelley Zieroth</name><affiliation wicri:level="4"><nlm:affiliation>University of Manitoba, Winnipeg, Manitoba, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>University of Manitoba, Winnipeg, Manitoba</wicri:regionArea><orgName type="university">Université du Manitoba</orgName><placeName><settlement type="city">Winnipeg</settlement><region type="state">Manitoba</region></placeName></affiliation></author><author><name sortKey="Yip, Cindy Y Y" sort="Yip, Cindy Y Y" uniqKey="Yip C" first="Cindy Y Y" last="Yip">Cindy Y Y. Yip</name><affiliation wicri:level="1"><nlm:affiliation>Heart and Stroke Foundation of Canada, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Heart and Stroke Foundation of Canada, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author></analytic><series><title level="j">CJC open</title><idno type="eISSN">2589-790X</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>Background</b></p><p>The literature indicates that cardiovascular disease (CVD; including stroke), older age, and availability of health care resources affect COVID-19 case fatality rates (CFRs). The cumulative effect of COVID-19 CFRs in global CVD populations and the extrapolated effect on access to health care services in the CVD population in Canada are not fully known. In this study we explored the relationships of factors that might affect COVID-19 CFRs and estimated the potential indirect effects of COVID-19 on Canadian health care resources.</p></div><div type="abstract" xml:lang="en"><p><b>Methods</b></p><p>Country-level epidemiological data were analyzed to study the correlation, main effect, and interaction between COVID-19 CFRs and: (1) the proportion of the population with CVD; (2) the proportion of the population 65 years of age or older; and (3) the availability of essential health services as defined by the World Health Organization Universal Health Coverage index. For indirect implications on health care resources, estimates of the volume of postponed coronary artery bypass grafting, percutaneous coronary intervention, and valve surgeries in Ontario were calculated.</p></div><div type="abstract" xml:lang="en"><p><b>Results</b></p><p>Positive correlations were found between COVID-19 CFRs and: (1) the proportion of the population with CVD (ρ = 0.40; </p></div><div type="abstract" xml:lang="en"><p><b>Conclusions</b></p><p>Countries with more prevalent CVD reported higher COVID-19 CFRs. Strain on health care resources is likely in Canada.</p></div><div type="abstract" xml:lang="fr"><p><b>Contexte</b></p><p>La littérature indique que les maladies cardiovasculaires (MCV, incluant les accidents vasculaires cérébraux), l’âge avancé et la facilité d’accès aux ressources de soins de santé ont une incidence sur les taux de létalité (TL) des cas de COVID-19. L’effet cumulatif du TL de la COVID-19 dans l’ensemble de la population atteinte de MCV et l’impact anticipé sur l'accès aux services de santé dans la population atteinte de MCV au Canada ne sont pas entièrement connus. Cette étude a exploré les liens entre les facteurs pouvant influencer le TL des cas de COVID-19 et a estimé le potentiel impact indirect de la COVID-19 sur les ressources de soins de santé au Canada.</p></div><div type="abstract" xml:lang="fr"><p><b>Méthodes</b></p><p>Les données épidémiologiques à l’échelle du pays ont été analysées pour étudier la corrélation, l’effet principal et l’interaction entre le TL de laCOVID-19 et : 1) la proportion de la population souffrant de MCV, 2) la proportion de la population ≥ 65 ans, et 3) l’accessibilité des services de santé essentiels tels que définis par l’indice de couverture sanitaire universelle (CSU) de l’Organisation Mondiale de la Santé. Pour les implications indirectes concernant les ressources de santé, des estimations du volume d’opération de pontages coronariens, d'interventions coronariennes percutanées et de chirurgies valvulaires reportées en Ontario ont été calculées.</p></div><div type="abstract" xml:lang="fr"><p><b>Résultats</b></p><p>Des corrélations positives ont été trouvées entre le TL de la COVID-19 et 1) la proportion de la population souffrant de MCV (ρ= 0,40, </p></div><div type="abstract" xml:lang="fr"><p><b>Conclusions</b></p><p>Les pays où les MCV sont plus répandues ont signalé un TL de la COVID-19 plus élevé. Il est probable que les ressources de soins de santé soient soumises à de fortes contraintes au Canada.</p></div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32691023</PMID><DateRevised><Year>2020</Year><Month>07</Month><Day>22</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2589-790X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Jul</Month></PubDate></JournalIssue><Title>CJC open</Title><ISOAbbreviation>CJC Open</ISOAbbreviation></Journal><ArticleTitle>COVID-19 Pandemic: Global Impact and Potential Implications for Cardiovascular Disease in Canada.</ArticleTitle><Pagination><MedlinePgn>265-272</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cjco.2020.06.003</ELocationID><Abstract><AbstractText Label="Background" NlmCategory="UNASSIGNED">The literature indicates that cardiovascular disease (CVD; including stroke), older age, and availability of health care resources affect COVID-19 case fatality rates (CFRs). The cumulative effect of COVID-19 CFRs in global CVD populations and the extrapolated effect on access to health care services in the CVD population in Canada are not fully known. In this study we explored the relationships of factors that might affect COVID-19 CFRs and estimated the potential indirect effects of COVID-19 on Canadian health care resources.</AbstractText><AbstractText Label="Methods" NlmCategory="UNASSIGNED">Country-level epidemiological data were analyzed to study the correlation, main effect, and interaction between COVID-19 CFRs and: (1) the proportion of the population with CVD; (2) the proportion of the population 65 years of age or older; and (3) the availability of essential health services as defined by the World Health Organization Universal Health Coverage index. For indirect implications on health care resources, estimates of the volume of postponed coronary artery bypass grafting, percutaneous coronary intervention, and valve surgeries in Ontario were calculated.</AbstractText><AbstractText Label="Results" NlmCategory="UNASSIGNED">Positive correlations were found between COVID-19 CFRs and: (1) the proportion of the population with CVD (ρ = 0.40; <i>P</i> = 0.001); (2) the proportion of the population 65 years of age or older (ρ = 0.43; <i>P</i> = 0.0005); and (3) Universal Health Coverage index (ρ = 0.27; <i>P</i> = 0.03). For every 1% increase in the proportion of the population 65 years of age or older or proportion of the population with CVD, the COVID-19 CFR was 9% and 19% higher, respectively. Approximately 1252 procedures would be postponed monthly in Ontario because of current public health measures.</AbstractText><AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">Countries with more prevalent CVD reported higher COVID-19 CFRs. Strain on health care resources is likely in Canada.</AbstractText><CopyrightInformation>© 2020 Canadian Cardiovascular Society. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Botly</LastName><ForeName>Leigh C P</ForeName><Initials>LCP</Initials><AffiliationInfo><Affiliation>Heart and Stroke Foundation of Canada, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin-Rhee</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Heart and Stroke Foundation of Canada, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kasiban</LastName><ForeName>Adrienne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Heart and Stroke Foundation of Canada, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swartz</LastName><ForeName>Richard H</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Sunnybrook Health Sciences Centre and Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mulvagh</LastName><ForeName>Sharon L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Dalhousie University, Halifax, Nova Scotia, Canada, and Department of Cardiovascular Medicine, Mayo Clinic, Rochester Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindsay</LastName><ForeName>M Patrice</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Heart and Stroke Foundation of Canada, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goia</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Heart and Stroke Foundation of Canada, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Eric E</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>Hotchkiss Brain Institute, Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hill</LastName><ForeName>Michael D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Hotchkiss Brain Institute, Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Field</LastName><ForeName>Thalia S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Vancouver Stroke Program, Division of Neurology, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krahn</LastName><ForeName>Andrew D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, and St Paul's and Vancouver General Hospital, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oudit</LastName><ForeName>Gavin Y</ForeName><Initials>GY</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, and Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zieroth</LastName><ForeName>Shelley</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Manitoba, Winnipeg, Manitoba, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yip</LastName><ForeName>Cindy Y Y</ForeName><Initials>CYY</Initials><AffiliationInfo><Affiliation>Heart and Stroke Foundation of Canada, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>CJC Open</MedlineTA><NlmUniqueID>101763635</NlmUniqueID><ISSNLinking>2589-790X</ISSNLinking></MedlineJournalInfo><OtherAbstract Type="Publisher" Language="fre"><AbstractText Label="Contexte" NlmCategory="UNASSIGNED">La littérature indique que les maladies cardiovasculaires (MCV, incluant les accidents vasculaires cérébraux), l’âge avancé et la facilité d’accès aux ressources de soins de santé ont une incidence sur les taux de létalité (TL) des cas de COVID-19. L’effet cumulatif du TL de la COVID-19 dans l’ensemble de la population atteinte de MCV et l’impact anticipé sur l'accès aux services de santé dans la population atteinte de MCV au Canada ne sont pas entièrement connus. Cette étude a exploré les liens entre les facteurs pouvant influencer le TL des cas de COVID-19 et a estimé le potentiel impact indirect de la COVID-19 sur les ressources de soins de santé au Canada.</AbstractText><AbstractText Label="Méthodes" NlmCategory="UNASSIGNED">Les données épidémiologiques à l’échelle du pays ont été analysées pour étudier la corrélation, l’effet principal et l’interaction entre le TL de laCOVID-19 et : 1) la proportion de la population souffrant de MCV, 2) la proportion de la population ≥ 65 ans, et 3) l’accessibilité des services de santé essentiels tels que définis par l’indice de couverture sanitaire universelle (CSU) de l’Organisation Mondiale de la Santé. Pour les implications indirectes concernant les ressources de santé, des estimations du volume d’opération de pontages coronariens, d'interventions coronariennes percutanées et de chirurgies valvulaires reportées en Ontario ont été calculées.</AbstractText><AbstractText Label="Résultats" NlmCategory="UNASSIGNED">Des corrélations positives ont été trouvées entre le TL de la COVID-19 et 1) la proportion de la population souffrant de MCV (ρ= 0,40, <i>P</i> = 0,001), 2) la proportion de la population ≥ 65 ans (ρ= 0,43, <i>P</i> = 0,0005), et 3) l’indice CSU (ρ= 0,27, <i>P</i> = 0,03). Pour chaque augmentation de 1 % de la proportion de la population ≥ 65 ans ou de la proportion de la population souffrant de MCV, le TL de la COVID-19 était respectivement supérieur de 9 % et 19 %. Environ 1 252 interventions seraient reportées chaque mois en Ontario en raison des mesures de santé publique actuelles.</AbstractText><AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">Les pays où les MCV sont plus répandues ont signalé un TL de la COVID-19 plus élevé. Il est probable que les ressources de soins de santé soient soumises à de fortes contraintes au Canada.</AbstractText></OtherAbstract></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>05</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>06</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32691023</ArticleId><ArticleId IdType="doi">10.1016/j.cjco.2020.06.003</ArticleId><ArticleId IdType="pii">S2589-790X(20)30072-X</ArticleId><ArticleId IdType="pmc">PMC7275173</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lancet. 2018 Nov 10;392(10159):1736-1788</Citation><ArticleIdList><ArticleId IdType="pubmed">30496103</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 May 19;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32427432</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Glob Health. 2020 Apr;8(4):e480</Citation><ArticleIdList><ArticleId IdType="pubmed">32109372</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Mar 28;395(10229):1054-1062</Citation><ArticleIdList><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2020 May;46(5):846-848</Citation><ArticleIdList><ArticleId IdType="pubmed">32125452</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2020 May 12;75(18):2352-2371</Citation><ArticleIdList><ArticleId IdType="pubmed">32201335</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 Mar 19;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32191259</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest. 2020 Jul;158(1):97-105</Citation><ArticleIdList><ArticleId IdType="pubmed">32304772</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Public Health. 2020 Apr 29;8:152</Citation><ArticleIdList><ArticleId IdType="pubmed">32411652</ArticleId></ArticleIdList></Reference><Reference><Citation>Pol Arch Intern Med. 2020 Apr 30;130(4):304-309</Citation><ArticleIdList><ArticleId IdType="pubmed">32231171</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Glob Health. 2018 Feb;6(2):e152-e168</Citation><ArticleIdList><ArticleId IdType="pubmed">29248365</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Cardiol. 2020 Mar 25;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 Apr 22;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>J Korean Med Sci. 2020 Mar 30;35(12):e137</Citation><ArticleIdList><ArticleId IdType="pubmed">32233163</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2020 May 25;192(21):E585-E586</Citation><ArticleIdList><ArticleId IdType="pubmed">32376644</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Cardiovasc Qual Outcomes. 2020 Apr;13(4):e006631</Citation><ArticleIdList><ArticleId IdType="pubmed">32182131</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Canada</li><li>États-Unis</li></country><region><li>Alberta</li><li>Manitoba</li><li>Ontario</li></region><settlement><li>Calgary</li><li>Toronto</li><li>Winnipeg</li></settlement><orgName><li>Université de Calgary</li><li>Université de Toronto</li><li>Université du Manitoba</li></orgName></list><tree><country name="Canada"><noRegion><name sortKey="Botly, Leigh C P" sort="Botly, Leigh C P" uniqKey="Botly L" first="Leigh C P" last="Botly">Leigh C P. Botly</name></noRegion><name sortKey="Field, Thalia S" sort="Field, Thalia S" uniqKey="Field T" first="Thalia S" last="Field">Thalia S. Field</name><name sortKey="Goia, Cristina" sort="Goia, Cristina" uniqKey="Goia C" first="Cristina" last="Goia">Cristina Goia</name><name sortKey="Hill, Michael D" sort="Hill, Michael D" uniqKey="Hill M" first="Michael D" last="Hill">Michael D. Hill</name><name sortKey="Kasiban, Adrienne" sort="Kasiban, Adrienne" uniqKey="Kasiban A" first="Adrienne" last="Kasiban">Adrienne Kasiban</name><name sortKey="Krahn, Andrew D" sort="Krahn, Andrew D" uniqKey="Krahn A" first="Andrew D" last="Krahn">Andrew D. Krahn</name><name sortKey="Lindsay, M Patrice" sort="Lindsay, M Patrice" uniqKey="Lindsay M" first="M Patrice" last="Lindsay">M Patrice Lindsay</name><name sortKey="Martin Rhee, Michelle" sort="Martin Rhee, Michelle" uniqKey="Martin Rhee M" first="Michelle" last="Martin-Rhee">Michelle Martin-Rhee</name><name sortKey="Oudit, Gavin Y" sort="Oudit, Gavin Y" uniqKey="Oudit G" first="Gavin Y" last="Oudit">Gavin Y. Oudit</name><name sortKey="Smith, Eric E" sort="Smith, Eric E" uniqKey="Smith E" first="Eric E" last="Smith">Eric E. Smith</name><name sortKey="Swartz, Richard H" sort="Swartz, Richard H" uniqKey="Swartz R" first="Richard H" last="Swartz">Richard H. Swartz</name><name sortKey="Yip, Cindy Y Y" sort="Yip, Cindy Y Y" uniqKey="Yip C" first="Cindy Y Y" last="Yip">Cindy Y Y. Yip</name><name sortKey="Zieroth, Shelley" sort="Zieroth, Shelley" uniqKey="Zieroth S" first="Shelley" last="Zieroth">Shelley Zieroth</name></country><country name="États-Unis"><noRegion><name sortKey="Mulvagh, Sharon L" sort="Mulvagh, Sharon L" uniqKey="Mulvagh S" first="Sharon L" last="Mulvagh">Sharon L. Mulvagh</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CardioCovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000371 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000371 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CardioCovidV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32691023
|texte= COVID-19 Pandemic: Global Impact and Potential Implications for Cardiovascular Disease in Canada.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32691023" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CardioCovidV1
| This area was generated with Dilib version V0.6.35. |  |